Wound Management Enhanced Via Maggot Therapy

The use of sterile maggots specifically produced for medical industries is not a new procedure, but one that is perhaps not utilized enough, suggested Olivier M. Lepage, DMV, PhD, Dipl. ECVS, from the University of Lyon in France, at the 10th International Congress of World Equine Veterinary Association (WEVA).

As described in his abstract, Lepage discussed the appropriate use of this "biosurgical therapy" in wound healing in horses. Specifically, he said maggot therapy is indicated in the management of:

  • Septic navicular bursitis;
  • Hoof infections/necrosis;
  • Other hoof diseases,
  • Fistulous withers;
  • Limb laceration and;
  • Abdominal wound dehiscence.

The role of maggot therapy in minimizing the spread of methicillin-resistant Staphylococcus aureus (MRSA) within and between patients is also being explored.

Lepage also described the use of both direct (free range) and indirect (contained) maggot therapy at the Congress of the European Society of Veterinary Orthopaedics and Traumatology (ESVOT) in Munich (Germany). This abstract is available at the OrthoVetSuperSite.  

About the Author

Stacey Oke, DVM, MSc

Stacey Oke, MSc, DVM, is a practicing veterinarian and freelance medical writer and editor. She is interested in both large and small animals, as well as complementary and alternative medicine. Since 2005, she's worked as a research consultant for nutritional supplement companies, assisted physicians and veterinarians in publishing research articles and textbooks, and written for a number of educational magazines and websites.

Stay on top of the most recent Horse Health news with FREE weekly newsletters from TheHorse.com. Learn More